SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 2130496

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 2130496

Global AI in Patient Management Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 237 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The global AI in patient management market size is expected to reach USD 60.96 Billion in 2034 from USD 10.81 Billion in 2025, growing at a CAGR of 21.19% during 2026-2034.This market is gaining momentum as healthcare organizations increasingly use artificial intelligence to improve patient coordination, monitoring, communication, and personalized care. AI systems can analyze clinical and administrative information to support patient prioritization, appointment management, risk identification, and treatment planning. Growing healthcare data volumes and increasing pressure to improve operational efficiency are encouraging hospitals, clinics, and digital health providers to adopt intelligent patient-management solutions that can assist healthcare professionals while improving patient experiences.

Major growth drivers include rising healthcare costs, increasing patient volumes, demand for personalized care, and the growing availability of electronic health records and connected health data. AI can help identify patients requiring additional attention, automate routine administrative processes, and support clinical decision-making. Predictive analytics can also assist healthcare organizations in identifying potential readmissions, treatment risks, and care gaps. Advances in natural language processing and machine learning are expanding AI applications across patient communication and healthcare workflows.

Future prospects are strong as healthcare systems increasingly transition toward proactive and data-driven care models. AI-powered platforms are expected to become more capable of integrating clinical records, patient-generated information, wearable-device data, and real-time monitoring. Greater emphasis on responsible AI, data privacy, interoperability, and regulatory compliance will influence adoption. As technology becomes more reliable and integrated into healthcare workflows, AI in patient management could support earlier interventions, better resource allocation, improved patient engagement, and more personalized healthcare delivery.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Delivery Mode

  • Cloud-based
  • On-premise

By Functionality

  • Enhanced Communication
  • Patient Education
  • Chatbots and Virtual Health Assistants
  • Predictive Analytics
  • Administrative and Streamlined Operations
  • Others

By Technology

  • Natural Language Processing (NLP) (Smart Assistance, OCR (Optical Character Recognition), Auto Coding, Text Analytics, Speech Analytics, Classification and Categorization)
  • Others

By Therapeutic Area

  • Health & Wellness
  • Chronic Disease Management
  • Others

By End Use

  • Healthcare Providers
  • Healthcare Payers
  • Others (Pharmaceutical Companies, Pharmacy)

COMPANIES PROFILED

  • MedAdvisor Solutions, Innovaccer Inc., EmpiRx Health LLC., IBM, Huma, mPulse Mobile, AllazoHealth, P360, Brand Engagement Network Inc., Oracle, Health Catalyst, Ada Health GmbH, Aiva Inc., Claritas Rx, AiCure, UST Global Inc.
Product Code: VMR112119359

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AI IN PATIENT MANAGEMENT MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Delivery Mode
  • 4.2. Cloud-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. On-premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AI IN PATIENT MANAGEMENT MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Functionality
  • 5.2. Enhanced Communication Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Patient Education Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Chatbots and Virtual Health Assistants Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Predictive Analytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Administrative and Streamlined Operations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AI IN PATIENT MANAGEMENT MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Technology
  • 6.2. Natural Language Processing (NLP) (Smart Assistance, OCR (Optical Character Recognition), Auto Coding, Text Analytics, Speech Analytics, Classification and Categorization) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL AI IN PATIENT MANAGEMENT MARKET: BY THERAPEUTIC AREA 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Therapeutic Area
  • 7.2. Health & Wellness Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Chronic Disease Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL AI IN PATIENT MANAGEMENT MARKET: BY END USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End Use
  • 8.2. Healthcare Providers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Healthcare Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Others (Pharmaceutical Companies, Pharmacy) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL AI IN PATIENT MANAGEMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Delivery Mode
    • 9.2.2 By Functionality
    • 9.2.3 By Technology
    • 9.2.4 By Therapeutic Area
    • 9.2.5 By End Use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Delivery Mode
    • 9.3.2 By Functionality
    • 9.3.3 By Technology
    • 9.3.4 By Therapeutic Area
    • 9.3.5 By End Use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Spain
    • 9.3.11 Russia
    • 9.3.12 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Delivery Mode
    • 9.4.2 By Functionality
    • 9.4.3 By Technology
    • 9.4.4 By Therapeutic Area
    • 9.4.5 By End Use
    • 9.4.6 China
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 India
    • 9.4.10 Australia
    • 9.4.11 South East Asia
    • 9.4.12 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Delivery Mode
    • 9.5.2 By Functionality
    • 9.5.3 By Technology
    • 9.5.4 By Therapeutic Area
    • 9.5.5 By End Use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Delivery Mode
    • 9.6.2 By Functionality
    • 9.6.3 By Technology
    • 9.6.4 By Therapeutic Area
    • 9.6.5 By End Use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL AI IN PATIENT MANAGEMENT INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 MedAdvisor Solutions
    • 11.2.2 Innovaccer Inc
    • 11.2.3 EmpiRx Health LLC
    • 11.2.4 IBM
    • 11.2.5 Huma
    • 11.2.6 MPulse Mobile
    • 11.2.7 AllazoHealth
    • 11.2.8 P360
    • 11.2.9 Brand Engagement Network Inc
    • 11.2.10 Oracle
    • 11.2.11 Health Catalyst
    • 11.2.12 Ada Health GmbH
    • 11.2.13 Aiva Inc
    • 11.2.14 Claritas Rx
    • 11.2.15 AiCure
    • 11.2.16 UST Global Inc
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!